Skip to main content
ILC Therapeutics home page
  • About us
    • Overview
    • Senior Management
    • Board of Directors
    • Investors
  • Platform
    • Background
    • Hybrid interferons
  • Our pipeline
    • Alfacyte™
  • News and events
    • Press releases
    • Newsroom
  • Contact

Contact

Contact us

  • +44 (0) 141 255 1038
  • contact@ilctherapeutics.com
  • 100 West George Street, Glasgow, Scotland, UK, G2 1PP

Media enquiries

  • Walbrook PR Ltd
    75 King William Street
    London
    EC4N 7BE
  • +44 (0)20 7933 8780
  • ILCTherapeutics@walbrookpr.com
ILC Therapeutics home page

ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles.

Linkedin

Navigation

  • About us
    • Overview
    • Senior Management
    • Board of Directors
    • Investors
  • Platform
    • Background
    • Hybrid interferons
  • Our pipeline
    • Alfacyte™
  • News and events
    • Press releases
    • Newsroom
  • Contact

Find Us

ILC Therapeutics Ltd.
100 West George Street
Glasgow
G2 1PP

See on map

Contact Us

  • +44 (0) 141 255 1038
  • contact@ilctherapeutics.com

© ILC Therapeutics — All rights reserved